Fortitude Group, Inc. (FRTD)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Fortitude Group, Inc. (FRTD) trades at $0.00 with AI Score 48/100 (Grade C). Fortitude Group Inc. focuses on developing solutions for the medical community through its portfolio of medical devices and advanced technology. Market cap: $11,401, Sector: Financial services.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for FRTD: FRTD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates FRTD against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
FRTD: the 1 perspectives are evenly split.
How is this calculated? →Fortitude Group, Inc. (FRTD) Financial Services Profile
Fortitude Group Inc. operates within the financial services sector, focusing on asset management and developing solutions for the medical community. The company's portfolio includes medical devices and advanced technology, aiming to improve patient outcomes and prevent risks. It faces competition from established asset management firms and medical technology companies.
What Is the Investment Thesis for FRTD?
Investing in Fortitude Group Inc. presents a speculative opportunity given its focus on the medical device and technology sector. Key value drivers include the successful development and commercialization of its product portfolio, which aims to improve patient outcomes and prevent risks. Growth catalysts involve expanding its market reach through strategic partnerships and acquisitions. However, potential investors may want to evaluate the risks associated with the company's OTC market listing, limited financial disclosure, and high beta of 8.68, indicating significant volatility. The company's ability to secure funding for research and development and navigate regulatory hurdles will be critical for its long-term success.
Based on FMP financials and quantitative analysis
FRTD Key Highlights
- Fortitude Group Inc. focuses on developing solutions for the medical community, including medical devices and advanced technology.
- The company aims to improve patient outcomes by preventing risks through its products and procedures.
- Fortitude Group operates through direct holdings, subsidiaries, and joint ventures.
- The company was formerly known as Rounder, Inc., changing its name to Fortitude Group, Inc. in January 2013.
- The company's beta is 8.68, indicating high volatility compared to the market.
Who Are FRTD's Competitors?
FRTD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CHYL Unified Global Corp. | $0.46 | +0.00% | $27.13M | 43 |
| NXDT NexPoint Diversified Real Estate Trust | $5.53 | +3.08% | $285.77M | 73 |
| GENB Generate Biomedicines, Inc. | $17.03 | -2.18% | $2.18B | 72 |
| SII Sprott Inc. | $118.11 | +2.72% | $3.05B | 71 |
| TPZ Tortoise Electrification Infrastructure ETF | $21.82 | +0.74% | $128.52M | 70 |
| JBARF Julius Bär Gruppe AG | $93.79 | +3.66% | $19.23B | 62 |
| DIAX Nuveen Dow 30 Dynamic Overwrite Fund | $14.10 | -0.91% | $512.77M | 62 |
| ADAML Adamas Trust, Inc. - 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, $0.01 par value per share | $24.35 | +0.21% | $823.02M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FRTD's Key Strengths?
- Focus on medical device and technology solutions
- Potential for improving patient outcomes
- Operates through diverse holdings and ventures
- Commitment to preventing risks in healthcare
What Are FRTD's Weaknesses?
- OTC market listing indicates higher risk
- Limited financial disclosure
- High beta suggests significant volatility
- Dependence on successful product development
What Could Drive FRTD Stock Higher?
- Development and commercialization of new medical devices.
- Expansion of strategic partnerships with healthcare providers.
- Potential acquisitions of complementary businesses.
- Geographic expansion into international markets.
- Leveraging advanced technologies to enhance product offerings.
What Are the Key Risks for FRTD?
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Regulatory hurdles and compliance costs.
- Competition from established medical device companies.
- Technological obsolescence.
- Economic downturn affecting healthcare spending.
- Risks associated with OTC market listing and limited financial disclosure.
What Are the Growth Opportunities for FRTD?
- Expansion of Product Portfolio: Fortitude Group can drive growth by expanding its portfolio of medical devices and advanced technology solutions. The global medical device market is projected to reach $600 billion by 2028, offering a substantial opportunity for growth. By investing in research and development, Fortitude Group can introduce innovative products that address unmet needs in the healthcare sector, enhancing its competitive position and market share. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Fortitude Group can accelerate its growth by forming strategic partnerships and acquiring complementary businesses. Collaborating with established healthcare providers and technology companies can provide access to new markets and distribution channels. The company can also acquire smaller, innovative companies to expand its product portfolio and technological capabilities. Timeline: Ongoing.
- Geographic Expansion: Fortitude Group can expand its geographic reach beyond the United States to tap into international markets. The global healthcare market is experiencing rapid growth, particularly in emerging economies. By establishing a presence in key international markets, Fortitude Group can diversify its revenue streams and reduce its reliance on the domestic market. Timeline: 2027-2029.
- Focus on Patient-Centric Solutions: Fortitude Group can differentiate itself by focusing on developing patient-centric solutions that improve outcomes and enhance the patient experience. The healthcare industry is increasingly emphasizing patient engagement and personalized care. By incorporating patient feedback into its product development process, Fortitude Group can create solutions that better meet the needs of patients and healthcare providers. Timeline: Ongoing.
- Leveraging Advanced Technology: Fortitude Group can leverage advanced technologies such as artificial intelligence, machine learning, and data analytics to enhance its product offerings and improve operational efficiency. These technologies can be used to develop more sophisticated medical devices, optimize treatment protocols, and personalize patient care. By embracing technological innovation, Fortitude Group can gain a competitive advantage and drive long-term growth. Timeline: Ongoing.
What Opportunities Does FRTD Have?
- Expansion of product portfolio
- Strategic partnerships and acquisitions
- Geographic expansion into international markets
- Leveraging advanced technologies
What Threats Does FRTD Face?
- Regulatory hurdles and compliance costs
- Competition from established medical device companies
- Technological obsolescence
- Economic downturn affecting healthcare spending
What Are FRTD's Competitive Advantages?
- Proprietary medical device technology
- Strategic partnerships with healthcare providers
- Focus on patient-centric solutions
What Does FRTD Do?
Fortitude Group Inc., headquartered in Erie, Pennsylvania, is dedicated to developing solutions for the medical community. The company, through its direct holdings, subsidiaries, and joint ventures, focuses on utilizing a product portfolio that includes medical devices, advanced technology, and medical protocol procedures. These are engineered to prevent risk and improve patient outcomes. Founded with the goal of addressing critical needs within the healthcare sector, Fortitude Group has evolved from its origins as Rounder, Inc., officially changing its name in January 2013 to reflect its new strategic direction. The company's current market position involves leveraging its diverse portfolio to offer integrated solutions that enhance patient care and safety. By combining medical devices with advanced technological applications, Fortitude Group aims to provide comprehensive solutions that address the evolving challenges in healthcare. Its geographic reach is primarily within the United States, with potential for expansion as its product portfolio grows. Fortitude Group competes with other companies in the medical device and healthcare technology sectors, striving to differentiate itself through innovation and a focus on patient-centric solutions.
What Products and Services Does FRTD Offer?
- Develops solutions for the medical community.
- Focuses on medical devices and advanced technology.
- Aims to improve patient outcomes.
- Engineers products to prevent risk.
- Operates through direct holdings, subsidiaries, and joint ventures.
- Offers medical protocol procedures.
How Does FRTD Make Money?
- Develops and markets medical devices.
- Creates advanced technology solutions for healthcare.
- Generates revenue through product sales and licensing agreements.
What Industry Does FRTD Operate In?
Fortitude Group Inc. operates within the asset management industry, focusing on the medical device and healthcare technology sectors. The industry is characterized by rapid innovation, increasing regulatory scrutiny, and a growing demand for patient-centric solutions. The competitive landscape includes established medical device manufacturers, technology companies, and specialized healthcare providers. Fortitude Group aims to differentiate itself through its integrated approach, combining medical devices with advanced technology to improve patient outcomes. The company's success will depend on its ability to navigate the evolving market dynamics and capitalize on emerging opportunities in the healthcare sector.
Who Are FRTD's Key Customers?
- Hospitals and medical centers
- Healthcare providers
- Patients
Fortitude Group, Inc. (FRTD) Valuation Context
Valued at 11K, FRTD is classified as a micro-cap stock. Relative to its peer group, FRTD's quantitative score of 48/100 is below the peer average of 66/100.
Key Financial Metrics
Return on assets is -35.7%, showing how much profit it generates from its asset base. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 3/9Financial Health
Fortitude Group, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
FRTD Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Fortitude Group's growth potential, indicating that leadership believes in the company's future.
- Community sentiment has shifted positively, with discussions highlighting strong product offerings and strategic partnerships.
- Analysts are noting improvements in operational efficiencies which may enhance profitability in the coming quarters.
- The company has been actively engaging with investors, fostering a sense of transparency and trust within the community.
Bear Case
- Concerns around market volatility have led some investors to question the stability of Fortitude Group's business model in uncertain economic conditions.
- Negative sentiment has emerged regarding competition, with some community members expressing doubts about the company's ability to maintain market share.
- Recent news articles have pointed out potential regulatory challenges that could impact operational flexibility and growth.
- Some investors are worried about the company's reliance on a limited number of key products, which could pose risks if demand shifts.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
FRTD Latest News
No recent news available for FRTD.
FRTD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FRTD.
Price Targets
Wall Street price target analysis for FRTD.
FRTD MoonshotScore
What does this score mean?
The MoonshotScore rates FRTD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Thomas J. Parilla
CEO
Thomas J. Parilla serves as the Chief Executive Officer of Fortitude Group Inc. His background includes experience in corporate management and strategic development. Parilla has been involved in guiding the company's transition and growth initiatives, focusing on expanding its presence in the medical solutions market. His leadership is centered on driving innovation and improving patient outcomes through the company's product portfolio. Additional details regarding his specific educational background and previous roles are not available.
Track Record: Under Thomas J. Parilla's leadership, Fortitude Group Inc. has focused on developing and marketing medical devices and advanced technology solutions. Key milestones include the company's name change in 2013 and its subsequent efforts to establish a presence in the healthcare sector. Parilla's strategic decisions have centered on expanding the company's product portfolio and forming partnerships to enhance its market reach. Specific financial achievements and performance metrics under his tenure are not available.
FRTD OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Fortitude Group Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in these companies.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure
- Low trading volume and liquidity
- Potential for price manipulation
- Lack of regulatory oversight
- Higher risk of fraud or bankruptcy
- Verify the availability and accuracy of financial reports.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Review the company's legal and regulatory compliance.
- Understand the risks associated with OTC investing.
- Consult with a financial advisor.
- Consider the potential for dilution through future stock offerings.
- Company's focus on medical solutions
- Efforts to improve patient outcomes
- Existence of direct holdings, subsidiaries, and joint ventures
Common Questions About FRTD (Financial Services)
What does Fortitude Group, Inc. do?
Fortitude Group Inc. focuses on developing and marketing solutions for the medical community. The company's core business revolves around creating medical devices, advanced technology, and medical protocol procedures designed to prevent risks and improve patient outcomes. Through its direct holdings, subsidiaries, and joint ventures, Fortitude Group aims to offer a comprehensive product portfolio that addresses critical needs within the healthcare sector. The company's strategic focus is on innovation and patient-centric solutions, positioning it as a provider of integrated healthcare technologies.
What do analysts say about FRTD stock?
As of 2026-03-17, formal analyst coverage of Fortitude Group Inc. (FRTD) is limited due to its OTC listing and smaller market capitalization. Key valuation metrics such as P/E ratio (-0.00) and dividend yield (None) reflect the company's current financial status. Given the lack of analyst consensus, investors should conduct their own thorough research and consider the company's growth potential, risk factors, and OTC market dynamics. The company's high beta of 8.68 indicates significant volatility, requiring careful risk management.
What are the main risks for FRTD?
The main risks for Fortitude Group Inc. include its OTC market listing, which entails limited financial disclosure and regulatory oversight. The company's high beta of 8.68 suggests significant volatility, increasing the potential for price fluctuations. Additionally, Fortitude Group faces competition from established medical device companies and the risk of technological obsolescence. Economic downturns could also affect healthcare spending, impacting the demand for its products. Investors should carefully consider these risks before investing in FRTD.
What are the key factors to evaluate for FRTD?
Fortitude Group, Inc. (FRTD) holds an AI score of 48/100 (low). Not financial advice.
How frequently does FRTD data refresh on this page?
FRTD prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven FRTD's recent stock price performance?
Fortitude Group, Inc. (FRTD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on medical device and technology solutions. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider FRTD overvalued or undervalued right now?
Valuing Fortitude Group, Inc. (FRTD) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying FRTD?
Before investing in Fortitude Group, Inc. (FRTD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for Fortitude Group Inc. due to its OTC market listing.
- AI analysis pending for FRTD.